Issue 53, 2025, Issue in Progress
From the journal:

RSC Advances

Correction: High-throughput screening of FDA-approved drugs identifies colchicine as a potential therapeutic agent for atypical teratoid/rhabdoid tumors (AT/RTs)

Phongthon Kanjanasirirat,abc   Kedchin Jearawuttanakul,c   Sawinee Seemakhan,c   Suparerk Borwornpinyo,cd   Patompon Wongtrakoongate,ef   Suradej Hongengcg  and  Sitthivut Charoensutthivarakul*acf  

* Corresponding authors

a School of Bioinnovation and Bio-based Product Intelligence, Faculty of Science, Mahidol University, Bangkok, Thailand
E-mail: sitthivut.cha@mahidol.ac.th
Tel: +66-2-201-5899

b Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok, Thailand

c Excellent Center for Drug Discovery (ECDD), Faculty of Science, Mahidol University, Bangkok, Thailand

d Department of Biotechnology, Faculty of Science, Mahidol University, Bangkok, Thailand

e Department of Biochemistry, Faculty of Science, Mahidol University, Bangkok, Thailand

f Center for Neuroscience, Faculty of Science, Mahidol University, Bangkok, Thailand

g Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

Abstract

Correction for ‘High-throughput screening of FDA-approved drugs identifies colchicine as a potential therapeutic agent for atypical teratoid/rhabdoid tumors (AT/RTs)’ by Phongthon Kanjanasirirat et al., RSC Adv., 2025, 15, 12331–12341, https://doi.org/10.1039/D5RA01341K.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/D5RA90136G
Article type
Correction
Submitted
11 Nov 2025
Accepted
11 Nov 2025
First published
18 Nov 2025
This article is Open Access
Creative Commons BY license

RSC Adv., 2025,15, 44991-44991

Permissions

Request permissions

Correction: High-throughput screening of FDA-approved drugs identifies colchicine as a potential therapeutic agent for atypical teratoid/rhabdoid tumors (AT/RTs)

P. Kanjanasirirat, K. Jearawuttanakul, S. Seemakhan, S. Borwornpinyo, P. Wongtrakoongate, S. Hongeng and S. Charoensutthivarakul, RSC Adv., 2025, 15, 44991 DOI: 10.1039/D5RA90136G

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements